These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34526531)

  • 21. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model.
    Ren C; Kumar S; Chanda D; Chen J; Mountz JD; Ponnazhagan S
    Stem Cells; 2008 Sep; 26(9):2332-8. PubMed ID: 18617688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury.
    Giri J; Das R; Nylen E; Chinnadurai R; Galipeau J
    Cell Rep; 2020 Feb; 30(6):1923-1934.e4. PubMed ID: 32049021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.
    Choi IK; Lee JS; Zhang SN; Park J; Sonn CH; Lee KM; Yun CO
    Gene Ther; 2011 Sep; 18(9):898-909. PubMed ID: 21451575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
    Lucas ML; Heller L; Coppola D; Heller R
    Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
    Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
    Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
    Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
    Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
    J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination efficacy with marrow mesenchymal stem cell against cancer was enhanced under simulated microgravity.
    Li J; Chen J; Li X; Qian Y
    Biochem Biophys Res Commun; 2017 Apr; 485(3):606-613. PubMed ID: 28238782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.
    Hughes RM; Simons BW; Khan H; Miller R; Kugler V; Torquato S; Theodros D; Haffner MC; Lotan T; Huang J; Davicioni E; An SS; Riddle RC; Thorek DLJ; Garraway IP; Fertig EJ; Isaacs JT; Brennen WN; Park BH; Hurley PJ
    Cancer Res; 2019 Jul; 79(14):3636-3650. PubMed ID: 31123087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
    Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
    J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.
    Kerkar SP; Goldszmid RS; Muranski P; Chinnasamy D; Yu Z; Reger RN; Leonardi AJ; Morgan RA; Wang E; Marincola FM; Trinchieri G; Rosenberg SA; Restifo NP
    J Clin Invest; 2011 Dec; 121(12):4746-57. PubMed ID: 22056381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration.
    Miloradovic D; Miloradovic D; Markovic BS; Acovic A; Harrell CR; Djonov V; Arsenijevic N; Volarevic V
    Stem Cells Int; 2020; 2020():8842659. PubMed ID: 32695181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages.
    Yamada K; Uchiyama A; Uehara A; Perera B; Ogino S; Yokoyama Y; Takeuchi Y; Udey MC; Ishikawa O; Motegi S
    Cancer Res; 2016 Jul; 76(14):4283-92. PubMed ID: 27197197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
    Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of paracrine immunotherapy in experimental brain tumors.
    Lesniak MS; Sampath P; DiMeco F; Viglione MP; Tyler BM; Pardoll DM; Brem H
    Neurosurg Focus; 2000 Dec; 9(6):e4. PubMed ID: 16817687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
    Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
    Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor effects of canine adipose tissue-derived mesenchymal stromal cell-based interferon-β gene therapy and cisplatin in a mouse melanoma model.
    Seo KW; Lee HW; Oh YI; Ahn JO; Koh YR; Oh SH; Kang SK; Youn HY
    Cytotherapy; 2011 Sep; 13(8):944-55. PubMed ID: 21846298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-21-Expressing Mesenchymal Stem Cells Prevent Lethal B-Cell Lymphoma Through Efficient Delivery of IL-21, Which Redirects the Immune System to Target the Tumor.
    Kim N; Nam YS; Im KI; Lim JY; Lee ES; Jeon YW; Cho SG
    Stem Cells Dev; 2015 Dec; 24(23):2808-21. PubMed ID: 26415081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.